scorecardresearch
Wednesday, August 27, 2025
TopicFDA

Topic: FDA

Tariff cloud looming, US study links Indian generic drugs with 54% higher severe adverse events

Researchers associated with The Ohio State University found that number of severe adverse events linked to generic drugs made in India was 54% higher than for those made in the US.

Govt says no plan to ban heartburn drug ranitidine, carcinogenic impurities within safe limits

In 2019, evidence showed that an impurity in drug degrades over time to form probable carcinogenic compound. Ranitidine is sold as heartburn medicine under names Rantac, Aciloc & Zinetac.

1st US FDA-approved drug invented in India set for local launch as part of combination antibiotic

Combination of enmetazobactam, invented by scientists associated with Chennai-based pharma firm Orchid Pharma in 2008, and antibiotic cefipime is used to treat severe bacterial infection.

‘Ban McDonald’s nationwide,’ says traders’ body after ‘fake cheese’ found in burger in Maharashtra

Such fraudulent practices cannot be tolerated, CAIT adds. This comes after Food & Drug Administration allegedly found counterfeit cheese at fast food giant's outlet in Ahmednagar.

US cracks down on healthcare product makers following cough syrup deaths overseas

Cough syrups made in India & Indonesia have been linked to deaths of over 300 children globally. Medicines were found to contain high levels of DEG, EG, leading to death.

Op Broader Sword: India, US join hands to crack down on shipments of ‘illicit’ drugs, medical devices

Operation targeted packages entering US from India through New York (JFK) & Chicago (ORD) International Mail Facilities (IMFs) last month. Over 500 shipments seized, Indian national held.

After Singapore, US now approves sale of lab-grown meat in restaurants, grocery stores

The US government’s approval to two California-based companies is being seen as a huge step for the alternative protein industry.

US FDA asks India’s Sun Pharma to halt trials on experimental dermatological drug

Sun Pharma said FDA has also stated that patients with alopecia areata on 12 mg dose of the drug deuruxolitinib should discontinue its use, Sun Pharma said.

US FDA takes new dengue vaccine by Japanese firm Takeda for priority review

Takeda has carried out phase 3 trials of the vaccine candidate and found it to be 80.2% effective in preventing symptomatic dengue cases after a year of vaccination.

‘No prescription sought, drugs under different names’ — Maharashtra FDA busts ‘abortion pill racket’

FDA officers in 13 parts of the state posed as customers and managed to easily procure the kits. FIRs lodged against e-commerce app, ‘unlicensed’ agency.

On Camera

India will absorb Trump tariff impact due to its Achilles’ heel

Like China, India remains a big domestic market, which will continue to attract investment, but the US tariffs will make India unattractive for future investments.

New insolvency frameworks to shorter timelines, how 2025 amendment bill proposes to transform IBC

New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.

Op Sindoor lesson: IAF chief bats for joint planning & coordination centre in Delhi, not theaterisation

Contrary to claims regarding implementation of theaterisation, ThePrint first reported on 17 June 2021 that it will be delayed. Now, ACM Singh bats for different structure.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.